MNT: Quality of Life (2022)
Author and Year:
Menard J, Payette H, et al. 2007
Quality of life in type 2 diabetes patients under intensive multitherapy.
Ménard J, Payette H, Dubuc N, Baillargeon J, Maheux P, Ardilouze J
Diabetes & Metabolism
Year of publication:
Randomized Controlled Trial
Risk of Bias Assessment Rating:
Patients with type 2 diabetes mellitus (1985 World Health Organization criteria) and receiving any therapy regimen, between 30 and 70 years of age and with hemoglobin A1c concentrations of 8% or greater were eligible to participate in the study.
Patients with hypoglycemia unawareness, severe or uncontrolled cardiovascular disease (defined as a cardiovascular event within the last year), dyspnea higher than class II,17 proteinuria greater than 300 mg/day, proliferative retinopathy (defined as growth of new blood vessels on the retina and posterior surface of the vitreous), chronic foot ulrs or wounds, or psychiatric disease or cognitive impairment interfering with treatment compliance. Also excluded were patients who were unable to perform the exercise program or detect sensation with the use of a 10-g monofilament.
To assess the impact of an intensive multitherapy (IMT) on perceived quality of life (QOL), attitudes, knowledge and diabetes self management in patients with poorly controlled type 2 diabetes
Centre Hospitalier Universitaire de Sherbrooke, Quebec, Canada
Source(s) of Funding:
Please specify names of funders:
This work was supported by the Clinical Research Centre of the Centre Hospitaler Universitaire de Sherbrooke and by grants from Brystol-Myers Squibb and the Quebec Diabetes Association.